Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.125 NZD -2.34%
Market Cap: 101.5m NZD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PEB Price Targets Summary
Pacific Edge Ltd

Wall Street analysts forecast PEB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PEB is 0.066 NZD with a low forecast of 0.051 NZD and a high forecast of 0.084 NZD.

PEB Lowest Forecast
Wall Street Target
0.051 NZD
60% Downside
PEB Average Forecast
Wall Street Target
0.066 NZD
47% Downside
PEB Highest Forecast
Wall Street Target
0.084 NZD
33% Downside
Lowest
Price Target
0.051 NZD
60% Downside
Average
Price Target
0.066 NZD
47% Downside
Highest
Price Target
0.084 NZD
33% Downside
Pacific Edge Ltd Competitors:
Price Targets
BIOPOR
Bioporto A/S
107% Upside
VRTX
Vertex Pharmaceuticals Inc
0% Upside
FOLD
Amicus Therapeutics Inc
89% Upside
PTCT
PTC Therapeutics Inc
15% Upside
BIOPOR
Bioporto A/S
107% Upside
VRTX
Vertex Pharmaceuticals Inc
0% Upside
FOLD
Amicus Therapeutics Inc
89% Upside
PTCT
PTC Therapeutics Inc
15% Upside
AZT
Arcticzymes Technologies ASA
6% Upside
KRRO
Korro Bio Inc
537% Upside
S
4599
StemRIM Inc
113% Upside
9926
Akeso Inc
6% Upside

Revenue
Forecast

Revenue Estimate
Pacific Edge Ltd

For the last 8 years the compound annual growth rate for Pacific Edge Ltd's revenue is 22%. The projected CAGR for the next 3 years is -9%.

22%
Past Growth
-9%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pacific Edge Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pacific Edge Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

See Also

Summary
PEB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEB stock valuation using valuation multiples.
Wall Street Estimates
PEB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PEB's stock price target?
Price Target
0.066 NZD

According to Wall Street analysts, the average 1-year price target for PEB is 0.066 NZD with a low forecast of 0.051 NZD and a high forecast of 0.084 NZD.

What is Pacific Edge Ltd's Revenue forecast?
Projected CAGR
-9%

For the last 8 years the compound annual growth rate for Pacific Edge Ltd's revenue is 22%. The projected CAGR for the next 3 years is -9%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.